跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYTGOBI 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LYTGOBI 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
LYTGOBI 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Taiho Pharma Netherlands B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 21, 2023
Approval ID
66ad8cb27a19d06b
Company
Taiho Pharma Netherlands B.V.
Type
Standard
Approval Details
Approval Id
66ad8cb27a19d06b
Drug Cima Aemps Name
LYTGOBI 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1231741001
Holder Company Name
Taiho Pharma Netherlands B.V.
Marketing Company Name
Taiho Pharma Netherlands B.V.
Authorization Date
2023-09-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
4 MG
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Taiho Pharma Netherlands B.V.
Active Ingredients
FUTIBATINIB
4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 21, 2023
Approval ID
66ad8cb27a19d06b
Type
Standard
Back to CIMA-AEMPS Approvals
